(Q37100706)

18 August 2017

1 reference

title

Update in diffuse parenchymal lung disease 2007. (English)

1 reference

18 August 2017

1 reference

2

Cory M Hogaboam

1 reference

18 August 2017

Athol U Wells

1

1 reference

PubMed ID

18316770

18 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

American Journal of Respiratory and Critical Care Medicine

18 August 2017

1 reference

18 August 2017

177

1 reference

18 August 2017

6

1 reference

18 August 2017

580-584

1 reference

Histopathologic diagnosis in diffuse lung disease: an ailing gold standard.

18 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Organizing pneumonia and lymphoplasmacytic inflammation predict treatment response in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Acute exacerbations of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Incidence and prevalence of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

British Thoracic Society Study on cryptogenic fibrosing alveolitis: Response to treatment and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

What is this thing called CFA?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Cyclophosphamide versus placebo in scleroderma lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Adult-onset pulmonary fibrosis caused by mutations in telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Early interstitial lung disease in familial pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Pulmonary Lymphangioleiomyomatosis in a Karyotypically Normal Man without Tuberous Sclerosis Complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Linking parenchymal disease progression to changes in lung mechanical function by percolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis: can we identify the right target genes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Gene expression profiling of familial and sporadic interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Impairment of alveolar macrophage transcription in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Dendritic cells accumulate in human fibrotic interstitial lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-gamma receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Local and circulating microchimerism is associated with hypersensitivity pneumonitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Expression of receptor for advanced glycation end products in sarcoid granulomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

Relationships between Early Inflammatory Response to Bleomycin and Sensitivity to Lung Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200801-056UP

10.1164/RCCM.200801-056UP

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18316770